RxDoctor Payments DataLook up a doctor →

Nicholas Gatz, MD

Family Medicine · Merriam, KSNPI 1063647527

Payments from drug & device makers

$12,703in general payments, 2019–2025

Across 798 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$812
  • Amgen$579
  • plus $5K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)175$2,778
Novo Nordisk73$1,110
AstraZeneca(2 entities)53$1,042
Lilly USA, LLC63$1,023
Pfizer77$812
Amgen37$579
Boehringer Ingelheim28$446
Bayer12$291
Abbott12$250
Kowa Pharmaceuticals America, Inc.16$241
Johnson & Johnson21$227
Takeda Pharmaceuticals U.S.A., Inc.12$223
Astellas Pharma US Inc12$219
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$180
GSK11$164
Ardelyx, Inc.8$148
Merck11$148
Shield Therapeutics Inc6$146
Mylan Specialty L.p.9$140
E.r. Squibb & Sons, L.L.C.8$140
Novartis9$139
Eisai Inc.6$129
Amarin Pharma, Inc.8$129
Sumitomo Pharma America, Inc.7$108
Biohaven Pharmaceutical Holding Company Ltd.6$105
Vanda Pharmaceuticals Inc.4$104
Boston Scientific5$95
Amneal Pharmaceuticals LLC5$83
Ironwood Pharmaceuticals, Inc6$82
Axsome Therapeutics, Inc.5$79
Sunovion Pharmaceuticals Inc.4$79
Sanofi Pasteur Inc.5$76
Paratek Pharmaceuticals, Inc.5$75
Ultragenyx Pharmaceutical Inc.4$67
Corium, LLC3$61
Otsuka America Pharmaceutical, Inc.4$60
Neos Therapeutics, LP4$59
Sanofi-aventis U.S. LLC2$59
Phathom Pharmaceuticals, Inc.5$57
Viatris Specialty LLC3$50
Supernus Pharmaceuticals, Inc.3$45
Biogen2$42
Nabriva Therapeutics, PLC3$41
Teva Pharmaceuticals USA, Inc.2$40
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$39
Lundbeck LLC2$38
Daiichi Sankyo Inc.2$37
Cequr Corporation1$36
Shire North American Group Inc3$35
Neurocrine Biosciences, Inc.2$35
Neurelis, Inc.2$33
Seqirus USA Inc1$29
Genentech USA, Inc.2$27
Averitas Pharma Inc.1$25
Currax Pharmaceuticals LLC2$24
Hologic Sales And Service, LLC1$20
Avanir Pharmaceuticals, Inc.1$18
Dexcom, Inc.1$17
Collegium Pharmaceutical, Inc.1$15
Tris Pharma Inc1$15

How this compares

$12,703 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas →

Medicare billing

Part B allowed, 2024
$93,986
Medicare patients
231
Services billed
3,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Merriam

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →